Vaccine · BLA
Pneumovax 23 (Pneumococcal vaccine polyvalent) NDC 0006-4837
Streptococcus pneumoniae type 1 capsular polysaccharide antigen 25 ug/.5mL + 22 more ingredients · Injection, Solution · Intramuscular, Subcutaneous · Merck Sharp & Dohme LLC
NDC codes
FDA NDC DirectoryProduct NDC (as listed)0006-4837Labeler and product segments. Claims need a package NDC.
Product NDC at billing width00006-4837Add the package segment from the table below.
| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0006-4837-03 | 0000648370300006483703 | 10 SYRINGE, GLASS in 1 CARTON (0006-4837-03) / .5 mL in 1 SYRINGE, GLASS (0006-4837-01)Marketed from Jul 21, 2014 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Pneumovax 23
- Generic name (nonproprietary)
- pneumococcal vaccine polyvalent
- Active ingredients
- Streptococcus pneumoniae type 1 capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 2 capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 3 capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 4 capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 5 capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 6b capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 7f capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 8 capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 9n capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 9v capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 10a capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 11a capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 12f capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 14 capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 15b capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 17f capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 18c capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 19f capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 19a capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 20 capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 22f capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 23f capsular polysaccharide antigen — 25 ug/.5mLStreptococcus pneumoniae type 33f capsular polysaccharide antigen — 25 ug/.5mL
- Dosage form
- Injection, Solution
- Route
- Intramuscular, Subcutaneous
- Labeler
- Merck Sharp & Dohme LLCNDC labeler code 0006
- Product type
- Vaccine
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 101094
- Marketing start
- Listing expires
- Other FDA classes
- Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Pneumococcal Vaccines (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)
- Identifiers
- Product ID 0006-4837_34f422ac-b31a-43fa-abd3-b5707327a8cdSPL ID 34f422ac-b31a-43fa-abd3-b5707327a8cd
- Pharmacologic class
- Inactivated Pneumococcal Vaccine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Immunization administration (CPT 90460–90474)
Giving a vaccine is reported separately from the vaccine product code, with an immunization administration code. Which code applies depends on the patient's age, the route and whether counselling was provided.
- NDC on a medical claim
N400006483703followed by a unit qualifier and the quantityPackage 00006-4837-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 0006-4837
- What is NDC 0006-4837?
- 0006-4837 is the product NDC for Pneumovax 23 (pneumococcal vaccine polyvalent), Streptococcus pneumoniae type 1 capsular polysaccharide antigen 25 ug/.5mL + 22 more ingredients injection, solution, listed with the FDA by Merck Sharp & Dohme LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Pneumovax 23 (Pneumococcal vaccine polyvalent).
- What is the active ingredient?
- Streptococcus pneumoniae type 1 capsular polysaccharide antigen, Streptococcus pneumoniae type 2 capsular polysaccharide antigen, Streptococcus pneumoniae type 3 capsular polysaccharide antigen, Streptococcus pneumoniae type 4 capsular polysaccharide antigen, Streptococcus pneumoniae type 5 capsular polysaccharide antigen, Streptococcus pneumoniae type 6b capsular polysaccharide antigen, Streptococcus pneumoniae type 7f capsular polysaccharide antigen, Streptococcus pneumoniae type 8 capsular polysaccharide antigen, Streptococcus pneumoniae type 9n capsular polysaccharide antigen, Streptococcus pneumoniae type 9v capsular polysaccharide antigen, Streptococcus pneumoniae type 10a capsular polysaccharide antigen, Streptococcus pneumoniae type 11a capsular polysaccharide antigen, Streptococcus pneumoniae type 12f capsular polysaccharide antigen, Streptococcus pneumoniae type 14 capsular polysaccharide antigen, Streptococcus pneumoniae type 15b capsular polysaccharide antigen, Streptococcus pneumoniae type 17f capsular polysaccharide antigen, Streptococcus pneumoniae type 18c capsular polysaccharide antigen, Streptococcus pneumoniae type 19f capsular polysaccharide antigen, Streptococcus pneumoniae type 19a capsular polysaccharide antigen, Streptococcus pneumoniae type 20 capsular polysaccharide antigen, Streptococcus pneumoniae type 22f capsular polysaccharide antigen, Streptococcus pneumoniae type 23f capsular polysaccharide antigen, Streptococcus pneumoniae type 33f capsular polysaccharide antigen.
- Who is the labeler?
- Merck Sharp & Dohme LLC, NDC labeler code 0006. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Pneumovax 23?
- 1 other product NDC are listed under this name. See all Pneumovax 23 NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Pneumovax 23 products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Pneumovax 23pneumococcal vaccine polyvalent | Streptococcus pneumoniae type 1 capsular polysaccharide antigen 25 ug/.5mL + 22 more ingredients | Injection, SolutionIntramuscular, Subcutaneous | Merck Sharp & Dohme LLC | 0006-4943 | 00006-4943-00 |
Other NDCs under BLA 101094
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Pneumovax 23pneumococcal vaccine polyvalent | Streptococcus pneumoniae type 1 capsular polysaccharide antigen 25 ug/.5mL + 22 more ingredients | Injection, SolutionIntramuscular, Subcutaneous | Merck Sharp & Dohme LLC | 0006-4943 |